Key Characteristics and Working Principle of Aptamers

Key Characteristics and Working Principles of Aptamers

1. What is an Aptamer?

An aptamer is a short, single-stranded oligonucleotide (DNA or RNA) obtained through in vitro selection, capable of binding to a specific target with high affinity and high specificity. Its name derives from the Latin “aptus” (meaning “to fit”) and the Greek “meros” (meaning “part”). It can be regarded as a chemical antibody, but its essence is nucleic acid rather than protein.

2. Key Characteristics

Compared to traditional antibodies, aptamers possess a series of outstanding advantages:

1. High Affinity and High Specificity

   • Can bind tightly to targets with dissociation constants (Kd) in the nanomolar (nM) or even picomolar (pM) range, similar to antibodies.

   • Capable of distinguishing between targets with subtle differences, e.g., distinguishing phosphorylated from non-phosphorylated states of the same protein, recognizing minor conformational changes in proteins, or differentiating structurally similar molecules (like caffeine and theophylline).

2. Extremely Broad Target Range

   • Targets are not limited to immunogenic substances. From ions, small molecules, drugs, and toxins to proteins, viruses, bacteria, cells, and even entire tissues, aptamers can potentially be selected for almost any target.

3. Chemical Synthesis and Modification

   • Can be produced on a large scale, at low cost, and with high purity in vitro via solid-phase synthesis, ensuring minimal batch-to-batch variation.

   • Easy to introduce site-specific chemical modifications during synthesis, such as fluorescent groups, biotin, thiols, amino groups, or unnatural bases, facilitating subsequent detection and immobilization without compromising binding ability.

4. Excellent Stability

   • Good thermal stability: DNA aptamers can withstand high temperatures (can renature after denaturation), facilitating storage and transport.

   • Strong chemical stability: Less susceptible to organic solvents, pH changes, etc.

   • Low immunogenicity (typically): As nucleic acids, they generally do not elicit strong immune responses in vivo.

5. Programmability and Reversibility

   • As nucleic acid sequences, their function can be regulated through sequence design.

   • Binding to targets is usually reversible (by changing ion concentration, temperature, adding competitors, etc.), allowing for reuse (e.g., in sensors).

6. Ease of Engineering

   • Can be easily fused with other functional modules (e.g., reporter genes, ribozymes, nanomaterials) using molecular biology techniques to construct multifunctional complexes.

Main Limitations:

• Susceptible to nuclease degradation in vivo (especially RNA aptamers), although stability can be significantly improved through chemical modifications (e.g., 2′-fluoro, 2′-O-methyl, LNA, phosphate backbone modifications).

• Small molecular weight leads to rapid renal clearance, requiring strategies like PEGylation or conjugation to larger molecules to extend half-life.

• The selection process (SELEX) is technically demanding, time-consuming, and not always 100% successful.

3. Working Principle

The core of the aptamer’s working principle lies in its three-dimensional structure formed by “induced fit” and its molecular recognition of the target molecule.

1. Structural Basis

• The single-stranded DNA or RNA sequence does not remain linear but forms intramolecular base pairs (creating stem-loops, hairpins, bulges, G-quadruplexes, etc.) that further fold into unique and stable three-dimensional structures (like pockets, clefts, planes, or platforms).

• This 3D structure binds to the precisely complementary shape, charge distribution, or chemical groups on the target molecule’s surface through non-covalent interactions such as hydrogen bonding, van der Waals forces, hydrophobic interactions, electrostatic interactions, and base stacking, much like a “key and lock” or “hand and glove” fit.

2. Mechanism of Action (Using Detection as an Example)

Aptamers themselves usually do not generate a directly detectable signal; their “work” requires coupling to a reporting system. Common mechanisms include:

• Conformational Switch/Signal-Off-On Mechanism:

  • The aptamer exists in one conformation when free and undergoes a conformational change upon target binding.

  • This property can be utilized by labeling the aptamer with a fluorophore and a quencher. Before binding, they are close, and fluorescence is quenched. Upon binding, the conformational change separates them, producing a fluorescent signal (similar to a molecular beacon).

• Steric Hindrance Mechanism:

  • The aptamer is immobilized on an electrode or gold nanoparticle surface.

  • Target binding creates steric hindrance that impedes electron transfer or causes changes in nanoparticle aggregation/dispersion state, leading to changes in electrical signal or color/spectrum.

• Competitive Displacement Mechanism:

  • The aptamer first binds to a reporter molecule (e.g., a labeled complementary strand, a mimic).

  • When the target is present, its stronger affinity competitively displaces the reporter molecule, resulting in a detectable signal change.

4. How to Obtain Aptamers? – SELEX Technology

The acquisition of aptamers relies on a core in vitro selection technology: Systematic Evolution of Ligands by EXponential enrichment (SELEX).

Basic Process:

1. Library Construction: Synthesize an oligonucleotide library containing up to 10^14 – 10^15 random sequences (with a central random region of 30-60 nucleotides flanked by fixed primer regions).

2. Binding/Selection: Incubate the library with the immobilized target molecule.

3. Separation/Washing: Wash away unbound or weakly bound sequences, retaining those that specifically bind to the target.

4. Elution and Amplification: Elute the bound sequences and amplify them via PCR (for DNA) or RT-PCR (for RNA) to obtain an enriched sub-library.

5. Iteration: Use the amplified product (rendered single-stranded, e.g., by denaturation) as input for the next selection round. Repeat steps 2-4, typically for 8-15 rounds.

6. Cloning and Sequencing: Clone and sequence the final enriched library to obtain individual aptamer sequences.

7. Characterization: Synthesize and purify individual sequences, and determine their binding affinity (Kd), specificity, and other parameters for the target.

5. Main Application Fields

Based on the above characteristics and principles, aptamers are widely used in:

• Diagnostics and Detection: As recognition elements in biosensors, lateral flow assays, ELISA-like assays, etc.

• Targeted Therapy: As “missiles” to deliver drugs, toxins, or nanocarriers specifically to diseased cells (e.g., in cancer).

• Molecular Regulation: Binding to and modulating the function of specific proteins, serving as research tools or potential therapeutics.

• Analytical Chemistry: As materials for solid-phase extraction or chromatographic stationary phases to enrich and separate targets.

• Imaging: Labeled with fluorescent dyes or radioisotopes for in vivo and in vitro bioimaging.

In summary, an aptamer is a functional nucleic acid obtained through in vitro selection, achieving high-specificity binding to targets via its precisely folded three-dimensional structure. Its core advantages lie in its chemical synthesizability, high stability, broad target applicability, and ease of engineering, demonstrating great potential in bioanalysis, medical diagnostics, therapy, and other fields. It serves as a powerful complement and even alternative to antibodies.